EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Norwogonin Attenuates Inflammatory Osteolysis and Collagen‐Induced Arthritis via Modulating Redox Signalling and Calcium Oscillations

Haojue Wang, Tao Yuan, Xiao Yu, Yi Wang, Changxing Liu, Ziqing Li, Shui Sun iD

Journal of Cellular and Molecular Medicine · 2025-03 · 29 (6)

DOI: 10.1111/jcmm.70492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 18.03.2025. Verfasst von Haojue Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Arthritis, Experimental, Osteolysis, Calcium Signaling, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Taishan Scholar Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Norwogonin is a flavonoid extraction derived from Scutellaria baicalensis . However, its potential mechanisms in the context of rheumatoid arthritis (RA) are unclear. This study investigates the specific effects and associated targets of Norwogonin in RA‐related inflammatory osteolysis. Network pharmacology was conducted to analyse the core targets and signalling pathways of Norwogonin in RA. In vitro experiments were carried out to explore the actual effects of Norwogonin on osteoclast behaviours and related signalling mechanisms. In vivo studies further validated the therapeutic effect of Norwogonin in collagen‐induced arthritis (CIA) mice. The network pharmacological analysis identified 18 shared targets between Norwogonin and RA, indicating a connection with inflammatory response and oxidoreductase activity. For biological validations, the results of in vitro experiments revealed 160 μM of Norwogonin inhibited LPS‐driven osteoclast differentiation and function. The qPCR assay and Western blot analysis also disclosed consistently diminished changes to osteoclastic marker genes and proteins due to Norwogonin treatment, including those for osteoclast differentiation (Traf6, Tnfrsf11a and Nfatc1), fusion (Atp6v0d2, Dcstamp and Ocstamp) and function (Mmp9, Ctsk and Acp5). Further mechanism study revealed Norwogonin suppressed LPS‐driven ROS production and calcium (Ca 2+ ) oscillations. Also, intraperitoneal injection of 30 mg/kg Norwogonin every other day successfully mitigated clinical arthritis progression and attenuated bone destruction in the CIA model. Our study scrutinises Norwogonin's therapeutic prospects in treating RA and illustrates its inhibitory effects and potential mechanism within LPS‐induced osteoclastogenesis and CIA mice, providing a basis for further translational research on Norwogonin in the treatment of RA‐related inflammatory osteolysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, ExperimentalOsteolysisCalcium SignalingInflammationAnimalsMiceOsteoclastsOxidation-ReductionMaleArthritis, RheumatoidSignal TransductionCell DifferentiationOsteogenesisCollagen

Stichwörter der Autor:innen

ERp57NorwogoninROScalcium oscillationsosteoclastrheumatoid arthritis

Substanzen

Collagen

Autor:innen und Institutionen

  • Department of Joint Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Department of Obstetrics and Gynecology, Jian Gong Hospital, Beijing, China.
  • Orthopaedic Research Laboratory, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.

ORCID-Profile: Shui Sun

Förderung

  • National Natural Science Foundation of China
  • Taishan Scholar Foundation of Shandong Province

Zitieren

APA

Wang, H., Yuan, T., Yu, X., Wang, Y., Liu, C., Li, Z., & Sun, S. (2025). Norwogonin Attenuates Inflammatory Osteolysis and Collagen‐Induced Arthritis via Modulating Redox Signalling and Calcium Oscillations. Journal of Cellular and Molecular Medicine, 29(6). https://doi.org/10.1111/jcmm.70492

Vancouver

Wang H, Yuan T, Yu X, Wang Y, Liu C, Li Z, et al. Norwogonin Attenuates Inflammatory Osteolysis and Collagen‐Induced Arthritis via Modulating Redox Signalling and Calcium Oscillations. Journal of Cellular and Molecular Medicine. 2025;29(6). doi:10.1111/jcmm.70492

BibTeX
@article{Wang2025,
  author = {Wang, Haojue and Yuan, Tao and Yu, Xiao and Wang, Yi and Liu, Changxing and Li, Ziqing and Sun, Shui},
  title = {Norwogonin Attenuates Inflammatory Osteolysis and Collagen‐Induced Arthritis via Modulating Redox Signalling and Calcium Oscillations},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  volume = {29},
  number = {6},
  doi = {10.1111/jcmm.70492}
}
Kostenlos starten →